Clinical trials
Terminated Phase 4 trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
164 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 7 |
| 2006 | 5 |
| 2007 | 10 |
| 2008 | 16 |
| 2009 | 13 |
| 2010 | 12 |
| 2011 | 6 |
| 2012 | 8 |
| 2013 | 15 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 11 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 164 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 20 |
| Hopital Foch | 10 |
| University Hospital, Strasbourg, France | 8 |
| Nantes University Hospital | 7 |
| Pfizer | 7 |
| Centre Hospitalier Universitaire de Saint Etienne | 6 |
| University Hospital, Grenoble | 5 |
| Centre Hospitalier Universitaire Dijon | 4 |
| University Hospital, Caen | 4 |
| University Hospital, Rouen | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 7 |
| Heart Failure | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| HIV Infections | 3 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Myocardial Infarction | 3 |
| Agnosia | 2 |
| Alcoholism | 2 |
| Anemia | 2 |
| Brain Injuries, Traumatic | 2 |
Trials
Showing 1 to 25 of 164. Each trial links to its page on Pharma Observatory.
64 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.